Pharmafile Logo
Pharmafocus logo
Advanced Search
chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …

Appointment
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 7, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen plenty of COVID-19 vaccine news; AstraZeneca has halted the paediatric trial of their jab amid …

News
Moderna building

UK begins rollout of Moderna COVID-19 vaccine

April 7, 2021
Research and Development COVID-19, COVID-19 vaccine, Moderna, Moderna vaccine, pharma, pharma news

The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …

News

Novartis and Artios Pharma to collaborate on DDR cancer therapies

April 7, 2021
Research and Development Novartis, RLT, oncology

Novartis and Artios Pharma have announced a global research collaboration to discover and validate next generation DNA damage response (DDR) …

News
astrazeneca_sign_sky

AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe

April 7, 2021
Research and Development AstraZeneca, COVID-19, Vaccine

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …

News

NICE recommends CBT, acupuncture, and anti-depressants for chronic pain

April 7, 2021
Research and Development NICE, antidepressant, chronic pain

A new NICE guideline on the assessment and management of chronic primary pain does not recommend the prescription of painkillers, …

News

Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial

April 6, 2021
Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine

Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …

News
Janssen sign

Janssen agrees $780 million deal for authorisation of Cidara flu treatment

April 6, 2021
Manufacturing and Production Janssen, cidara, influenza

Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 …

News
Pfizer's Lipitor tablet

Pfizer vaccine 91.3% effective after six months, Phase III study shows

April 6, 2021
Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …

News

Alnylam publish successful results from Phase III study of ultra-rare disease

April 6, 2021
Manufacturing and Production

Alnylam Pharmaceuticals, a RNAi therapeutics company, have published successful results from their Phase III study of lumasiran, the first ever …

News

FDA approves first new ADHD drug in a decade

April 6, 2021
Manufacturing and Production ADHD, FDA, paediatric

The FDA have approved the first new drug for the treatment of attention deficit hyperactivity disorder (ADHD) in over a …

News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 2, 2021
COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news

In the last week, a number of new COVID-19 developments have emerged; Novavax has delayed 100 million vaccines to the …

News
european_commission_web

EC grants marketing authorisation to Angelini Pharma’s epilepsy treatment

April 1, 2021

Angelini Pharma have announced that the European Commission (EC) have granted marketing authorisation for Ontozry (cenobamate) for the treatment of …

News

New Sanofi Sarclisa treatment for multiple myeloma approved by FDA

April 1, 2021
FDA, FDA Approval, Sanofi, Sarclisa, multiple myeloma

Sanofi’s Sarclisa drug has been approved by the FDA in combination with carfilzomib and dexamethasone (Kd) for the treatment of …

News

Newron announce successful results from schizophrenia study

April 1, 2021
schizophrenia

Newron, a biopharmaceutical company focused on novel therapies, have announced the initial results from two short-term exploratory studies assessing the …

News

BD’s rapid COVID-19 test granted Emergency Use Authorization by FDA

April 1, 2021
BD, COVID-19, COVID-19 testing, EUA, FDA

The FDA has granted Emergency Use Authorization (EUA) for Becton, Dickinson and Company’s (BD) rapid antigen test to be used …

News

NICE recommends Kineret for Still’s disease treatment

April 1, 2021
NICE

Sobi has today announced a NICE recommendation of Kineret (anakinra) as a first-line biologic therapeutic option for still’s disease, including …

News
1558469633615

The Truth Behind the £1.8 Million Drug

March 31, 2021
Manufacturing and Production FDA, NHS, NICE

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …

Feature
hsm_mobile_clinical_trial_istock-872676342

Real-world evidence and clinical research diversity

March 31, 2021
Research and Development rwe

Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …

Feature
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 31, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup

The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026